Albert Schweitzer Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lambaréné Gabon (1913)

Organization Overview

First Clinical Trial
2002
NCT00217451
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Albert Schweitzer Hospital | Medical research Unit, Albert Schweitzer Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma in Situ (Phase 3)

Cervical Intraepithelial Neoplasia (Phase 3)

Fever (Phase 4)

Helminthiasis (Phase 4)

Hemorrhagic Fever, Ebola (Phase 1)

Hemorrhagic Fevers, Viral (Phase 1)

Intestinal Diseases (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 2)

Neoplasms (Phase 3)

Schistosomiasis (Phase 2)

Schistosomiasis haematobia (Phase 2)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 22
  • # of Trial APIs: 23